4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-119097
Chief Technical Officer sold 27,890 shares at $32.07 ($894,329)
- Chief Technical Officer acquired 27,890 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2023-11-14 | Option exercise 10b5-1 | +27,890 | $6.80 | $189,652 | 31,631 | D |
| Shulman Joseph Chief Technical Officer | 2023-11-14 | Sale 10b5-1 | −27,890 | $32.07 | $894,329 | 3,741 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2023-11-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −27,890 | 35,860 | D | ||
| Open-market sales · 27,890 sh · avg $32.07 · $894,329 | |||||||
Loading xslF345X05/tm2330902-3_4seq1.xml…